The right information at the right time can mean the difference between a breakthrough and a dead end

Septerna sells GPCR program to Vertex for $48 million Merck KGgA collaborates with Exscientia plc in deal

antagonists BenevolentAI, Exscientia on the comeback trail after securing separate AI drug discovery deals

Deak, A. K ´ onigstorfer, M. Mozhayeva, Y. Sara, T.C. Südhof, and ¨ E.T. Kavalali. 2001.

Exclusive Deal for Scientists Residing and Working in Developing Nations If you live and work  in a developing

GPCR phosphorylation immunoassay GPCR Binders, Drugs, and more Identification of 1,3,8-triazaspiro[4.5]decane Drug Discovery Nexus Salipro Biotech will participate in BioKorea2024 Domain Therapeutics Appoints Sean

Avoid the professional threat of flawed data interpretations that can lead to costly dead ends and missed

Exclusive Deal for Scientists Residing and Working in Developing Nations If you live and work  in a developing

This shift does not mean founders need more patents or heavier legal work. When momentum slows, deals quietly disappear. 👉 Biotech fundraising does not stop because investors turns analysis into investor confidence How IP Expectations Are Evolving Toward 2026 👉 What does this mean

to progress its proprietary CCR8 antibody candidate to the clinic Novo strikes another obesity drug deal

Exclusive Deal for Scientists in Developing Nations If you reside and work in a developing country, complete

Exclusive Deal for Scientists Residing and Working in Developing Nations If you live and work  in a developing

This is particularly important when dealing with receptor subtypes that exhibit significant similarity

Being a premium member means you get to enjoy all the freebies plus: Access to the recorded classes Discounted GPCR courses - because who doesn't love a good deal? 

This is particularly important when dealing with receptor subtypes that exhibit significant similarity

Industry News Sosei Heptares and Neurocrine Biosciences won Out-Licensing Deal of the Year from Locust

to optimize transmembrane domain providing significantly increased binding affinity and providing a means molecules in the library are specific for the target receptor rather than irrelevant cell surface targets, meaning Since shape space exploration is specifically focused on the ‘message’ site in the TM domain, this means This leads to strikingly long in vitro receptor occupancy durations (at least seven days), meaning that There is a great deal of scientific and business interest in solving this problem, and the last two years